Our resident #optogenetics expert @DrLylaElfay explains its @NobelPrize win and how it has moved beyond #neuroscience signalsblog.ca/a-nobel-for-o…
Signals retweeted
Researchers are learning to crack the blood-brain barrier to get drugs more easily into the brain. This has opened doors for treating a rare genetic disorder and is being tested in Phase 3 trials for Alzheimer's.
My latest in @NatGeo: nationalgeographic.com/healt…
Women are most commonly diagnosed with #dysautonomia. What is it & can #stemcells make a difference in treating the improper functioning of the autonomic nervous system? Ellie Kroeger explores the efficacy of treating it with MSCs signalsblog.ca/raising-aware…
A recent #deeptech event in Toronto suggests there is optimism that #quantumcomputing can have a meaningful impact on accelerating the commercialization of cell and gene therapies. Read @msstaceyerin's blog post signalsblog.ca/right-turn-ex… #DeepTechBioLab
Don't forget to vote for the #CellsISee People's Choice Award by October 7, 2026. #Sciart #contest hosted by CCRM and @StemCellNetwork
Vote here: facebook.com/media/set/?set=…
Signals retweeted
A fifth cell and gene therapy product has been approved in the US this year.
Today, the FDA announced approval of an AAV gene therapy developed by ARM member Ultragenyx to treat pediatric patients with Sanfilippo syndrome Type A. 1/2
fda.gov/news-events/press-an…
Banner week for #DeepTechBioLab: 1st a workshop at @IEEEQuantumWeek & then an event in the @biolabs @UofT space, with presentations & a panel. Want to learn more how we are bringing together #DeepTech companies with #lifesciences? ccrm.ca/deeptech-bio-lab/ @IonQ_Inc @KausarSamli
Just as @CBCNews is reporting about doctor #deepfake videos, @msstaceyerin has a timely blog post exploring the topic of who we can trust online with our health: signalsblog.ca/right-turn-he… Studies from @CaulfieldTim, Megan Munsie, @pewresearch @CMA_Docs
Signals retweeted
ICYMI: my call for Japan to do more to stop its huge & growing unproven stem cell/regenerative clinic industry after some deaths and many adverse events ipscell.com/2026/09/amid-pat… @ISSCR @ISCTglobal @CaulfieldTim @Signalsblogs
How do we make CGTs more accessible to patients globally? In the new episode of our podcast, @bambi_grilley & #StaciArnold explore manufacturing & delivery challenges, regulation, P3s & more. Listen where you stream podcasts or at ccrm.ca/podcast. @KristaLambComms
📣 Signals is looking for talented bloggers to write about the #regenerativemedicine and #CGT fields. signalsblog.ca/
If you’re passionate about cutting-edge science and can turn complex ideas into compelling content, we want to hear from you. DM us to learn more #scicomm
The 2026 #CellsISee People’s Choice Award voting is now open! "Like" your favourite and the lucky winner will receive $500 at #TMM2026. The #sciart #contest is co-hosted with @StemCellNetwork Vote here: facebook.com/media/set/?vani… Pls RT
Signals retweeted
🤩 Hope you're excited for our next guest, Dr. Yonatan Stelzer at @WeizmannScience!
The Stelzer Lab investigates how cell fate and identity are established during #embryonic development using single-cell and epigenomic approaches. 🧫
Check out his latest work: bit.ly/3UsGAsB
Signals retweeted
Inspiring Canada’s next generation of thinkers and problem-solvers starts with empowering educators! Our expanded free, bilingual STEM programming suite gives teachers even more turnkey, Canadian-context tools to bring into their classrooms. Read more:bit.ly/3V0CjaZ
Signals retweeted
Scientists stress-tested genes across 22 million human immune cells—using real cells from real donors, not lab models.
Emma Dann & Ronghui Zhu break down why this massive new dataset could reshape cancer immunotherapy and autoimmune treatment.
bit.ly/4xhJxKi
Signals retweeted
Dr. Lisa Barrett, Professor in the Department of Medicine at Dalhousie University, calls for a bolder immunization future.
The goal is bigger than avoiding infection. It is giving people the freedom to work, learn, create, and live without being derailed by preventable disease.
That vision is explored by Dr. Barrett alongside Wendy Zatylny, President & CEO of BIOTECanada, with David D. Jones, Managing Director of Merck Canada, guiding the discussion.
Featured in The Future of Life Sciences Expert Series, presented by Merck Canada.
Signals retweeted
After battling leukemia and receiving a stem cell transplant, Liam knows firsthand the impact a donor can have. 🧡
Now a Gift of Life Campus Ambassador at Clemson University, Liam shares his experience at the 2026 Campus Ambassador Retreat.
#CureBloodCancer #YouCure
Signals retweeted
What's the latest in cell and gene therapy? Catch up here: hubs.ly/Q04wthsD0
>Ocugen announced that it has dosed the first patient in its global Phase III trial for OCU410
> Genprex has partnered with Andelyn Biosciences to advance its diabetes gene therapy program
> Complement Therapeutics has completed its Phase I/II cohort 2 dosing of its gene therapy for geographic atrophy
Signals retweeted
Celebrating 20 years of iPS cells with a $200 contest ipscell.com/2026/09/celebrat… Please RT #stemcells #stemcells





















